Skip to main content
. 2021 Mar 31;21:98. doi: 10.1186/s12871-021-01291-z

Table 1.

Clinicodemographic data

PSI group (n = 20) Control group (n = 21) P-value
Gender (F/M) 11 / 9 9/ 12 0.44
Age (yr) 49.85 ± 11.80 43.90 ± 12.14 0.12
Weight (kg) 60.9 ± 11.46 66.60 ± 11.12 0.11
Height (cm) 162.60 ± 6.10 165.29 ± 6.75 0.19
ASA class (I/II) 8 / 12 13 / 8 0.16
Preoperative NRS 0.75 ± 0.44 (5.01) 0.62 ± 0.50 0.37
Duration of surgery (min) 118.50 ± 40.50 110.71 ± 27.99 0.48
Duration of anesthesia (min) 145.50 ± 40.84 137.62 ± 28.97 0.48
Total sufentanil (μg) 27.75 ± 4.72 28.57 ± 5.73 0.62
Total remifentanil (μg) 710.00 ± 228.61 704.76 ± 160.39 0.93
Operative blood loss (mL) 200.00 ± 79.47 200.00 ± 75.83 1.00
Intra-operative fluids (mL) 1677.50 ± 443.81 1514.29 ± 304.20 0.18
Urine output (mL) 545.00 ± 229.93 476.19 ± 210.13 0.32
Histopathological diagnosis (Thymoma/Lymphoma/Other) 13 / 3 / 4 13 / 4 / 4 0.94

Data are mean ± standard deviation or number (proportion) of patients